Comments
Loading...
Petros Pharma (PTPI) Forecast
NewsEarningsPetros Pharma (PTPI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPetros Pharma (NASDAQ:PTPI) Stock Quotes, Forecast and News Summary
Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Petros Pharma (PTPI) stock?
You can purchase shares of Petros Pharma (NASDAQ:PTPI) through any online brokerage.
Who are Petros Pharma (PTPI) competitors?
Other companies in Petros Pharma’s space includes: Biofrontera (NASDAQ:BFRI), NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharma (NASDAQ:PCSA), Titan Pharma (NASDAQ:TTNP) and cbdMD (AMEX:YCBD).
What is the forecast, or price target, for Petros Pharma (PTPI) stock?
Petros Pharma has a consensus price target of $4.00.
What is the current price for Petros Pharma (PTPI)?
The stock price for Petros Pharma (NASDAQ: PTPI) is $0.2507 last updated November 15, 2024 at 1:06 PM EST.
Does Petros Pharma (PTPI) pay a dividend?
There are no upcoming dividends for Petros Pharma.
When is Petros Pharma (NASDAQ:PTPI) reporting earnings?
Petros Pharma’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Petros Pharma (PTPI) going to split?
There is no upcoming split for Petros Pharma.
What sector and industry does Petros Pharma (PTPI) operate in?
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.